Home > Insider Trading > Filing (0000950170-25-022512)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1595097	Corbus Pharmaceuticals Holdings Inc.	CRBP	Pharmaceutical Preparations (2834)	464348039

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1626003	Yuval Cohen	C/O Corbus Pharmaceuticals Holdings, Inc 500 River Ridge Drive Norwood MA 02062	Chief Executive Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.0001 Per Share	Disposition	2025-02-14	7,134	$8.76	138,187	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024 and the sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.30 to $9.14. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
This amount includes 123,561 unvested RSUs subject to each grant's vesting schedule as previously reported.